Current position:Home >Product >
4-Pyridinecarboxamide, N-(3,4,6,7-tetrahydro-9-methyl-4-oxo-1-phenylpyrrolo(3,2,1-jk)(1,4)benzodiazepin-3-yl)-
4-Pyridinecarboxamide, N-(3,4,6,7-tetrahydro-9-methyl-4-oxo-1-phenylpyrrolo(3,2,1-jk)(1,4)benzodiazepin-3-yl)-(245329-99-1)
- Name: 4-Pyridinecarboxamide, N-(3,4,6,7-tetrahydro-9-methyl-4-oxo-1-phenylpyrrolo(3,2,1-jk)(1,4)benzodiazepin-3-yl)-
- Synonyms:CI-1018;245329-99-1;05127JZ9KQ;CI-1118;UNII-05127JZ9KQ;4-Pyridinecarboxamide, N-(3,4,6,7-tetrahydro-9-methyl-4-oxo-1-phenylpyrrolo(3,2,1-jk)(1,4)benzodiazepin-3-yl)-;SCHEMBL6307929;KYFWUBJMTHVBIF-UHFFFAOYSA-N;AKOS040751177;Q27236055;N-(6-Methyl-12-oxo-9-phenyl-1,10-diazatricyclo[6.4.1.04,13]trideca-4(13),5,7,9-tetraen-11-yl)pyridine-4-carboxamide
- Molecular Formula:C24H20N4O2
- Molecular Weight:396.4
- CAS Registry Number:245329-99-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.245329-99-1 CI-1018
Assay:>98% Appearance:Solid powder Package:inquiry Transportation:inquiry Application:CI-1018 is a selective type 4 phosphodiesterase inhibitor associated with vasculitis. CI-1018 has been in development to suppress inflammation.
Min. Order:0
Supplier:BOC Sciences [
United States]

Other Product
- 365429-36-3/4-{2-[4-(Methanesulfonyl)phenyl]-4-(3-methylphenyl)-1,3-thiazol-5-yl}-2-(piperidin-1-yl)pyridine
- 72788-90-0/(6-Aminopyrazin-2-yl)methanol
- 1220038-68-5/3-(2-Phenoxyethoxy)azetidine
- 886763-00-4/[3-(3-Bromo-phenyl)-propyl]-methyl-amine
- 1219802-60-4/Ranolazine-D8 Dihydrochloride
- 1041581-59-2/3-chloro-N-cyclopentyl-5-(trifluoromethyl)pyridin-2-amine
- 1391033-22-9/7-Bromo-1,1,1,2,2,3,3-heptafluoroheptane
- 374080-21-4/Proteasome-IN-1
- 1262006-21-2/4-(3-Acetylphenyl)-2-nitrobenzoic acid
- 1309980-79-7/5-Bromo-2-(neopentyloxycarbonyl)phenylboronic acid
- 1116097-04-1/5-Methoxy-2-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile
- 1374258-45-3/7-(trifluoromethyl)-1H-indazole-5-carboxylic acid
- 1138445-24-5/2-(1,1-Difluoroethyl)-1-fluoro-3-(trifluoromethyl)benzene
- 1159833-34-7/3,6-Dimethylimidazo[1,2-a]pyridine-2-carboxylic acid
- 885056-45-1/4-(3-(Benzyloxy)-4-(difluoromethoxy)phenyl)pyrrolidin-2-one
- 1185073-53-3/3-(4-Methylphenoxy)pyrrolidine hydrochloride
- 1346597-58-7/2-[2-(Cbz-amino)phenyl]-1,3-dioxolane
- 874948-49-9/5-(4-Methoxyphenyl)-15-(4-methylphenyl)-10-phenyl-20-(2,4,6-trimethylphenyl)porphyrin
- 54523-80-7/2-(2,3-Dichlorobenzoyl)pyridine
- 245329-99-1/4-Pyridinecarboxamide, N-(3,4,6,7-tetrahydro-9-methyl-4-oxo-1-phenylpyrrolo(3,2,1-jk)(1,4)benzodiazepin-3-yl)-
- 1160251-13-7/3-Ethoxy-4-[(3-fluorobenzyl)oxy]benzoyl chloride
- 1220034-47-8/1-(2-Amino-4-methylphenyl)-3-pyrrolidinol
- 1261080-26-5/Naltrexone-d3
- 353557-38-7/2,6-Difluoro-4-methylphenol
- 4735-64-2/Beclomethasone 21-acetate
- 2006277-89-8/Ethyl 3-[Hydroxy(3-pyridyl)methyl]isoxazole-4-carboxylate
- 1373920-92-3/4-Fluoro-3-methyl-5-(trifluoromethyl)benzonitrile
- 1119451-00-1/5-{[(3,5-Dimethylisoxazol-4-yl)methoxy]methyl}-2-furoic acid
- 1706445-96-6/3,4-Dihydro-1H-benzo[4,5]imidazo[2,1-c][1,4]thiazine-8-carboxylic acid 2-oxide
- 108964-33-6/GTPgammaS